ISOL-Coretech has established itself as a pioneering force in the medical imaging industry, consistently pushing the boundaries of MRI technology for over two decades.
ISOL-Coretech has established strong market leadership through a diverse portfolio of MRI systems, including the 1.5T CHORUS, 3.0T FORTE and 0.5T ENCORE. We have built strategic partnerships with global industry leaders such as Hitachi Medical Corp., strengthening our international presence and competitiveness. In addition, we successfully commercialized innovative bone mineral densitometry systems, including OSTEOPLAN and OSTEOPRIMA, with more than 400 units sold in Korea alone.
ISOL-Coretech has pioneered cutting-edge imaging solutions, including the development of 7.0T MRI systems, MR-guided HIFU therapy platforms, and integrated PET-MRI technologies. We have also advanced cardiac imaging capabilities and established a strong technological foundation for next-generation, AI-enhanced diagnostic imaging solutions.
Launching next-generation AI-powered 0.6T MRI systems specifically designed for emerging markets. Maintaining our commitment to innovation while ensuring accessibility and affordability in healthcare imaging. Expanding partnerships globally to bring advanced diagnostic capabilities to underserved populations.

Our product development history showcases continuous innovation across multiple technology platforms, from early bone density systems through advanced therapeutic imaging solutions. Each generation has built upon previous successes while incorporating cutting-edge technology to meet evolving clinical needs.

1996-1998: Foundation 1.0T MRI systems establishing our core imaging capabilities and market entry

1998-1999: Diversification 3.0T MRI technology demonstrating high-field imaging expertise and innovation

2000-2003: Market Leadership 3.0T and 1.5T MRI systems establishing strong market position and reliability

2005-2008: Accessibility Focus 0.5T and 0.35T MRI systems bringing imaging technology to broader markets

2009-2015: Therapeutic Innovation MR-guided HIFU/LIFU systems combining diagnostic imaging with targeted therapy capabilities

2023: AI-Enhanced Future AI-powered 0.6T/1.5T MRI and Brain 7T MRI representing next-generation intelligent imaging